Bharat Biotech founder Dr Krishna Ella bats for incentives, tax breaks for patented products, innovation
Queried about the need for three doses of the COVID-19 vaccine instead of just one, Ella said his company was working on the issue.
Nagpur: Bharat Biotech founder Dr Krishna Ella has batted for "research linked incentives" and tax breaks for new products based on breakthrough and patented innovation done within the country. He was speaking to reporters on the sidelines of the 72nd Indian Pharmaceutical Conference underway here."Research-linked incentive for Indian companies is very important. I would request the ministry...
Nagpur: Bharat Biotech founder Dr Krishna Ella has batted for "research linked incentives" and tax breaks for new products based on breakthrough and patented innovation done within the country. He was speaking to reporters on the sidelines of the 72nd Indian Pharmaceutical Conference underway here.
Read also: Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin
Bharat Biotech International Limited is an Indian multinational biotechnology company headquartered in Genome Valley, Turakapally, Hyderabad. The company was founded by Krishna Ella in 1996.
It is engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.
Read also: Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd